Some companies are cutting out insurers and bringing clinics to the office to address rising health care costs.
Diabetes
Posted inCost of Care
Ozempic Hype Forces Employer Calls on Obesity Coverage
Employers are facing a big dilemma: How do they pay for the new highly effective and popular obesity medications without breaking the bank?
Posted inCost of Care
How Patents Help Keep Obesity Drug Prices Sky-High
A recent JAMA study sheds light on how the manufacturers of a class of popular weight-loss drugs have avoided competition from more affordable generics.
Posted inCost of Care
What to Expect When Medicare and Pharma Finally Negotiate Drug Prices
We explain how Medicare’s historic price negotiations with drugmakers will work, and the impact they could have.
Posted inPublic Health
Three Health Policy Stories to Watch in 2023
In 2023, states will pursue new abortion laws, restart Medicaid eligibility checks and Medicare will begin to flex its new power to negotiate drug prices.
Posted inHealth Equity
Good Intentions Gone Awry
Why has a little-known program designed to help hospitals and clinics that serve low-income people become so controversial?
Posted inCost of Care
Digging Into the Growth in 340B Contract Pharmacies
Paula Chatterjee shares new research on the whether a popular discount drug program is reaching the patients it was designed to support.
Posted inCost of Care
The Sky-High Price of Insulin and What Lawmakers Are Trying To Do About It
We explore the high cost of insulin in the U.S. and Congress’ latest push to address those prices with Kaiser Health News reporter Bram Sable-Smith. d
Posted inHealth Technology
How Tech Can Shrink Racial Disparities in Medicine
Kosali Simon on research showing how digital tools shrunk the number of unnecessary amputations among Black diabetics.
Posted inCost of Care
Trump and Drug Prices
Lowering prescription drug prices continues to be one of President Trump’s top goals. What has he actually accomplished so far?